Correlation of Tumor Absorbed Dose with Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA.

Saved in:
Bibliographic Details
Title: Correlation of Tumor Absorbed Dose with Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA.
Authors: Kao YH; Department of Nuclear Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia; yung.kao@mh.org.au., Pook D; Department of Medical Oncology, Cabrini Hospital, Malvern, Victoria, Australia.; Faculty of Medicine, Monash University, Clayton, Victoria, Australia., Shapiro J; Department of Medical Oncology, Cabrini Hospital, Malvern, Victoria, Australia.; Faculty of Medicine, Monash University, Clayton, Victoria, Australia., Frydenberg M; Faculty of Medicine, Monash University, Clayton, Victoria, Australia.; Urology Research Department, Cabrini Hospital, Malvern, Victoria, Australia; and., Sivaratnam D; Department of Nuclear Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia.; GenesisCare, Cabrini Hospital, Malvern, Victoria, Australia.
Source: Journal of nuclear medicine technology [J Nucl Med Technol] 2026 Jun 03; Vol. 54 (2), pp. 149-152. Date of Electronic Publication: 2026 Jun 03.
Publication Type: Journal Article
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0430303 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5675 (Electronic) Linking ISSN: 00914916 NLM ISO Abbreviation: J Nucl Med Technol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1535-5675
DOI:10.2967/jnmt.125.270563